Toby Vaughn Selected Research

Inhalation Administration

1/2021	Comparative bioavailability of inhaled treprostinil administered as LIQ861 and Tyvaso® in healthy subjects.
10/2020	Pharmacokinetics and tolerability of LIQ861, a novel dry-powder formulation of treprostinil.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toby Vaughn Research Topics

Disease

2	Pulmonary Arterial Hypertension 01/2021 - 10/2020

Drug/Important Bio-Agent (IBA)

2	treprostinil FDA Link 01/2021 - 10/2020
2	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2021 - 10/2020
2	SolutionsIBA 01/2021 - 10/2020

Therapy/Procedure

2	Inhalation Administration 01/2021 - 10/2020